VI
NVCR icon

Vestcor Inc’s NovoCure NVCR Stock Holding History

Vestcor Inc’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,236
Closed -$93K – 1310
2023
Q2 		$93K Hold
2,236
– – ﹤0.01% 934
2023
Q1 		$134K Hold
2,236
– – ﹤0.01% 974
2022
Q4 		$164K Buy
2,236
+18
+0.8% +$1.35K 0.01% 985
2022
Q3 		$169K Buy
2,218
+31
+1% +$2.42K 0.01% 979
2022
Q2 		$152K Buy
2,187
+709
+48% +$53.4K 0.01% 974
2022
Q1 		$122K Sell
1,478
-1,232
-45% -$90.8K ﹤0.01% 1049
2021
Q4 		$203K Sell
2,710
-400
-13% -$40.2K 0.01% 858
2021
Q3 		$361K Sell
3,110
-171
-5% -$25.9K 0.01% 673
2021
Q2 		$728K Buy
3,281
+1,547
+89% +$301K 0.02% 552
2021
Q1 		$229K Hold
1,734
– – 0.01% 791
2020
Q4 		$300K Hold
1,734
– – 0.01% 643
2020
Q3 		$193K Hold
1,734
– – 0.01% 670
2020
Q2 		$103K Buy
+1,734
New +$114K 0.01% 690

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Vestcor Inc's NVCR Position: Q3 2023 in Review

Vestcor Inc sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 2,236 shares — an estimated $93K sold.

Vestcor Inc first reported a position in NVCR in Q2 2020 and held it in 13 quarters. The position peaked at $728K in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Vestcor Inc reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Vestcor Inc sold 2,236 NovoCure shares in Q3 2023, an estimated $93K.
  • Vestcor Inc first reported a position in NovoCure in Q2 2020 and held it in 13 quarters.
  • Vestcor Inc's NovoCure position peaked at $728K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Vestcor Inc's 13F filing for Q3 2023, filed 14 Nov 2023.